Ms. Trisha Cassidy reports

AURORA CANNABIS INTRODUCES THE COMPANY'S FIRST INHALABLE RESIN CARTRIDGES FOR PATIENTS IN THE UNITED KINGDOM

Aurora Cannabis Inc. has made medical cannabis concentrates available to patients in the United Kingdom. This launch marks the company's meaningful step in offering its proprietary cultivar-specific inhalable cannabis extracts in the U.K. market. These products are available to patients in Canada and Australia and this launch reinforces Aurora's commitment to expanding patient access to an even greater variety of high-quality, premium medical cannabis globally.

"As a company dedicated to patient care and ensuring we regularly listen to patient feedback -- we recognized a real need for a convenient and discreet consumption option and are excited to introduce a new cannabis format at a promised level of quality," said Trisha Cassidy, managing director, Aurora U.K. and Ireland. "Our launch of inhalable cannabis cartridges are another step forward in our mission to provide physicians with a larger variety of high-quality medical cannabis that can meet the growing needs and wishes of patients here in the U.K. We look forward to receiving feedback from physicians and patients with this expanded offering."

The two novel cultivar-specific Aurora 1.2-gram resin cartridges have been developed from two highly sought-after proprietary cultivars: Sourdough (indica) and Electric Honeydew (sativa). The inhalation method of these cartridges offers an ideal solution for fast and controlled delivery of medical cannabis.

Key benefits of cannabis inhalers include:

• Exceptional flavour profiles -- connected to popular flower products, these strain-specific cartridges use high-quality terpenes and pure extracts to deliver rich and authentic flavours;
• High potency -- ensures a powerful, consistent, controllable experience with each dose;
• Safety and quality -- manufactured in state-of-the-art facilities, adhering to strict TGA (Therapeutic Goods Administration) GMP (good manufacturing practice) quality control and safety standards; these cartridges contain no additives, representing the pinnacle of cannabis purity;
• User-friendly design -- easy to use, making it a convenient, portable and discreet choice for patients.

Aurora's industry-leading portfolio of cannabis products is available nationwide for cannabis retailers to offer. Patients may contact their clinics for further information or consult their doctors.

About Aurora Cannabis Inc.

Aurora is opening the world to cannabis, serving both the medical and consumer markets across Canada, Europe, Australia and New Zealand. Headquartered in Edmonton, Alta., Aurora is a pioneer in global cannabis, dedicated to helping people improve their lives. The company's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co., as well as international brands Pedanios, IndiMed and CraftPlant. Aurora also has a controlling interest in Bevo Farms Ltd., North America's leading supplier of propagated agricultural plants. Driven by science and innovation and with a focus on high-quality cannabis products, Aurora's brands continue to break through as industry leaders in the medical, wellness and adult recreational markets wherever they are launched.

Aurora's common shares trade on the Nasdaq Stock Market and the Toronto Stock Exchange under the symbol ACB.

We seek Safe Harbor.